Hepion Pharmaceuticals, Inc. - 8-K Filing

Hepion Pharmaceuticals increased authorized common shares to 750 million from prior levels (Items: 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 9.01 Financial Statements and Exhibits (d) Exhibits 3)

SEC EDGAR ·

Tickers: $HEPA

Read the full article at SEC EDGAR

More Regulatory news